Eli Lilly Stock Forecast

Stock Price Forecast

According to 31 analysts polled by S&P Global, Eli Lilly stock has a consensus rating of "Buy" and an average price target of $1,223. The average 1-year stock price forecast is 2.64% higher than the current stock price, while the lowest is $850 (-28.64%) and the highest is $1,500 (+25.92%).

Price Target: $1,223 (+2.64%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$850	$1,223	$1,251	$1,500
Change	-28.64%	+2.64%	+5.02%	+25.92%

Analyst Ratings

The average analyst rating for Eli Lilly stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	17	18	18	18	18	18
Buy	4	6	6	6	6	6
Hold	7	6	6	6	5	5
Sell	1	1	0	0	1	1
Strong Sell	0	0	1	1	1	1
Total	29	31	31	31	31	31

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Risinger Leerink Partners	Leerink Partners	Buy Maintains $1,119 → $1,232	Buy	Maintains	$1,119 → $1,232	+3.43%	Jun 25, 2026
Kerry Holford Berenberg Bank	Berenberg Bank	Hold Maintains $1,050 → $1,135	Hold	Maintains	$1,050 → $1,135	-4.72%	Jun 22, 2026
Emily Field Barclays	Barclays	Buy Maintains $1,400	Buy	Maintains	$1,400	+17.53%	Jun 22, 2026
Geoff Meacham Citi	Citi	Buy Maintains $1,500	Buy	Maintains	$1,500	+25.92%	Jun 16, 2026
Evan Seigerman BMO Capital	BMO Capital	Buy Maintains $1,300	Buy	Maintains	$1,300	+9.13%	Jun 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

85.26B

from 65.18B

30.81%

from 65.18B

Revenue Next Year

98.32B

from 85.26B

15.33%

from 85.26B

EPS This Year

36.21

from 24.21

49.56%

from 24.21

EPS Next Year

44.46

from 36.21

22.78%

from 36.21

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	28.32B	28.54B	34.12B	45.04B	65.18B	85.26B
Revenue Growth	15.40%	0.79%	19.56%	32.00%	44.70%	30.81%
Gross Profit	21.35B	21.91B	27.04B	36.63B	54.13B	70.90B
Gross Margin	75.38%	76.77%	79.25%	81.31%	83.04%	83.16%
Operating Income	8.27B	8.65B	10.33B	17.04B	29.70B	40.61B
Net Income	5.58B	6.24B	5.24B	10.59B	20.64B	30.99B
EPS	-	-	-	-	24.21	36.21
EPS Growth	-	-	-	-	86.37%	49.56%
Forward PE	31.77	46.27	53.37	35.13	34.33	32.90
Dividend / Share	3.40	3.92	4.52	5.20	6.00	6.83
Dividend Growth	-	15.29%	15.31%	15.04%	15.38%	13.83%
Free Cash Flow	5.46B	5.28B	292.33M	1.35B	1.95B	23.23B
No. Analysts	-	-	-	-	-	26

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	93.1B
Avg	85.3B
Low	81.9B

Revenue Growth

Revenue Growth	2026	2027	2028
High	42.8%
Avg	30.8%
Low	25.7%

EPS Forecast

EPS	2026	2027	2028
High	39.91
Avg	36.21
Low	27.66

EPS Growth

EPS Growth	2026	2027	2028
High	64.8%
Avg	49.6%
Low	14.3%